Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11603531 Methods and compositions for modulating splicing

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Skyhawk Therapeutics
Skyhawk Therapeutics
0
Date Filed
October 15, 2021
0
Date of Patent
March 14, 2023
0
Patent Applicant
Skyhawk Therapeutics
Skyhawk Therapeutics
0
Patent Application Number
17502824
0
Patent Citations
‌
US Patent 10195196 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
‌
US Patent 10196639 Modulation of gene expression and screening for deregulated protein expression
0
‌
US Patent 10252984 Inhibiting G protein coupled receptor 6 kinase polypeptides
‌
US Patent 10377742 AMPK-activating heterocyclic compounds and methods for using the same
0
‌
US Patent 10358427 Modulators of indoleamine 2,3-dioxygenase
‌
US Patent 10006027 Methods for modulating Ataxin 2 expression
‌
US Patent 10053697 Programmable alternative splicing devices and uses thereof
‌
US Patent 10076519 Substituted pyridazines as skeletal muscle modulators
‌
US Patent 10093678 Azaspiro derivatives as TRPM8 antagonists
‌
US Patent 10112923 1,2,4-triazine-4-amine derivatives
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11603531
0
Patent Primary Examiner
‌
Kristin A Vajda
0
CPC Code
‌
C12N 2310/333
0
‌
C07D 401/14
0
‌
C07D 403/14
0
‌
C07D 451/02
0
‌
C07D 451/04
0
‌
C12N 15/113
0
‌
C07D 471/04
0
‌
C07D 471/08
0
‌
C07D 471/10
0
‌
C07D 487/08
0
•••

Find more entities like US Patent 11603531 Methods and compositions for modulating splicing

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.